Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Abizaid

Showing results (271-280 of 306) with videos related to

Pageof 31
Sort By:
International Journal of Cardiology|May 22, 2025
Percutaneous or surgical revascularization in patients with severe left main coronary artery disease in Latin America: A GRADE clinical practice guidelinePablo Lamelas, Michel Pompeu Sá, Ariel Izcovich, et al.
Journal of the American College of Cardiology|November 12, 2021
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic RiskTullio Palmerini, Antonio Giulio Bruno, Björn Redfors, et al.
International Journal of Cardiology|July 9, 2025
Corrigendum to "Percutaneous or surgical revascularization in patients with severe left main coronary artery disease in Latin America: A GRADE clinical practice guideline" [International Journal of Cardiology Volume 436, 1 October 2025, 133401]Pablo Lamelas, Michel Pompeu Sá, Ariel Izcovich, et al.
JAMA|November 2, 2013
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trialFausto Feres, Ricardo A Costa, Alexandre Abizaid, et al.
International Journal of Cardiology. Heart & Vasculature|August 4, 2021
High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort studyPatrícia O Guimarães, Francis R de Souza, Renato D Lopes, et al.
Journal of the American College of Cardiology|October 8, 2025
Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position StatementSimone Fezzi, Patrick W Serruys, Bernardo Cortese, et al.
Journal of the American College of Cardiology|April 22, 2017
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary StentingTullio Palmerini, Letizia Bacchi Reggiani, Diego Della Riva, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
European Heart Journal|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
Atherosclerosis|February 28, 2026
Association of cancer on coronary atherosclerotic burden and plaque rupture: Insights from the BRAVADO studyVinicius Bocchino Seleme, Isabela Bispo Santos da Silva Costa, Bruna Pileggi, et al.
Pageof 31

Showing results (271-280 of 306) with videos related to

Sort By:
Pageof 31
International Journal of Cardiology|May 22, 2025
Percutaneous or surgical revascularization in patients with severe left main coronary artery disease in Latin America: A GRADE clinical practice guidelinePablo Lamelas, Michel Pompeu Sá, Ariel Izcovich, et al.
Journal of the American College of Cardiology|November 12, 2021
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic RiskTullio Palmerini, Antonio Giulio Bruno, Björn Redfors, et al.
International Journal of Cardiology|July 9, 2025
Corrigendum to "Percutaneous or surgical revascularization in patients with severe left main coronary artery disease in Latin America: A GRADE clinical practice guideline" [International Journal of Cardiology Volume 436, 1 October 2025, 133401]Pablo Lamelas, Michel Pompeu Sá, Ariel Izcovich, et al.
JAMA|November 2, 2013
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trialFausto Feres, Ricardo A Costa, Alexandre Abizaid, et al.
International Journal of Cardiology. Heart & Vasculature|August 4, 2021
High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort studyPatrícia O Guimarães, Francis R de Souza, Renato D Lopes, et al.
Journal of the American College of Cardiology|October 8, 2025
Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position StatementSimone Fezzi, Patrick W Serruys, Bernardo Cortese, et al.
Journal of the American College of Cardiology|April 22, 2017
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary StentingTullio Palmerini, Letizia Bacchi Reggiani, Diego Della Riva, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
European Heart Journal|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
Atherosclerosis|February 28, 2026
Association of cancer on coronary atherosclerotic burden and plaque rupture: Insights from the BRAVADO studyVinicius Bocchino Seleme, Isabela Bispo Santos da Silva Costa, Bruna Pileggi, et al.
Pageof 31